Not applicableLooking for participantsNCT06928909What this trial is testingLeukemia Adapted ProtocolWho this might be right forAcute Myeloid Leukaemia Baylor College of Medicine 30
Large-scale testing (Phase 3)Enrolling By InvitationNCT06544109What this trial is testingVenetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia PatientsWho this might be right forAcute Promyelocytic Leukemia The First Affiliated Hospital of Soochow University 98
Very early researchNot Yet RecruitingNCT06786299What this trial is testingClinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.Who this might be right forRelapsed/Refractory Acute Myeloid Leukemia(AML) First Affiliated Hospital of Zhejiang University 18
Early research (Phase 1)Study completedNCT01378416What this trial is testingPharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemia Eisai Inc. 16
Testing effectiveness (Phase 2)Ended earlyNCT03113071What this trial is testingSafety and Activity of Digoxin With Decitabine in Adult AML and MDSWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes Fox Chase Cancer Center 1
Early research (Phase 1)Not Yet RecruitingNCT07841002What this trial is testingCLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Liping Dou 12
Testing effectiveness (Phase 2)Study completedNCT01295307What this trial is testingClofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Technische Universität Dresden 86
Early research (Phase 1)WithdrawnNCT05720988What this trial is testingTagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03701295What this trial is testingPinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 RearrangementWho this might be right forAcute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT07512700What this trial is testingVenetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic LeukemiaWho this might be right forAcute Monocytic Leukemia Chinese PLA General Hospital 204
Not applicableStudy completedNCT06463639What this trial is testingFLT3 Clonal Evolution in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia National Taiwan University Hospital 1,213
Not applicableUnknownNCT05983172What this trial is testingMulti-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia National Taiwan University Hospital 1,500
Early research (Phase 1)Study completedNCT00867230What this trial is testingFTS Study in Patients With Advanced Hematologic MalignanciesWho this might be right forMyelodysplastic SyndromeLeukemia M.D. Anderson Cancer Center 18
Large-scale testing (Phase 3)UnknownNCT00111345What this trial is testingTherapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and AdolescentsWho this might be right forMyeloid Leukemia University Hospital Muenster 550
Testing effectiveness (Phase 2)Study completedNCT00006019What this trial is testingPhenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerWho this might be right forLeukemiaLung CancerLymphoma+3 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT02472145What this trial is testingAn Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyWho this might be right forLeukemia, Myeloid, Acute Janssen Research & Development, LLC 326
Early research (Phase 1)Study completedNCT00006239What this trial is testingPhenylbutyrate and Tretinoin in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT04742101What this trial is testingPhase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Institut de Recherches Internationales Servier 57
Early research (Phase 1)UnknownNCT05731219What this trial is testingUTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18